New Position for Price Controls on Pharma Within USTR Proposed
Rep. Vern Buchanan, R-Fla., and Rep. Jodey Arrington, R-Texas, reintroduced a bill that would add a position at the Office of the U.S. Trade Representative for identifying and reporting annually on foreign price-setting for pharmaceuticals, and to recommend trade remedies. The USTRx Act would call his position the chief pharmaceutical trade negotiator.
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
“American patients are paying more for life-saving medicines because foreign countries are free-riding on U.S. investment and innovation,” Buchanan said in an Aug. 4 press release. “This is not only unfair, it’s unsustainable.”